Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Clinical Pharmacology and Therapeutics
|
November 24, 2001
Red wine decreases cyclosporine bioavailability
S M Tsunoda, R Z Harris, U Christians, et al.
Clinical Pharmacology and Therapeutics
|
February 17, 2001
The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups
L M Mancinelli, L Frassetto, L C Floren, et al.
Clinical Pharmacology and Therapeutics
|
October 23, 1997
Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses
C Olbricht, C Wanner, T Eisenhauer, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 1, 1991
Investigations on the metabolic pathways of cyclosporine: I. Excretion of cyclosporine and its metabolites in human bile--isolation of 12 new cyclosporine metabolites
U Christians, S Strohmeyer, R Kownatzki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 1, 1991
Contribution of cyclosporin metabolites to immunosuppression in liver-transplanted patients with severe graft dysfunction
H J Schlitt, U Christians, J Bleck, et al.
Clinical Chemistry
|
September 1, 1996
Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry
F Streit, U Christians, H M Schiebel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 1999
Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver
W Jacobsen, G Kirchner, K Hallensleben, et al.
Pharmacology
|
August 18, 1999
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and Neoral
D M Canafax, W D Irish, H B Moran, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
November 25, 2000
Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants
U Christians, W Jacobsen, N Serkova, et al.
Pharmacology
|
January 1, 1989
Urinary excretion of ciclosporin and 17 of its metabolites in renal allograft recipients
J S Bleck, H J Schlitt, U Christians, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Clinical Pharmacology and Therapeutics
|
November 24, 2001
Red wine decreases cyclosporine bioavailability
S M Tsunoda, R Z Harris, U Christians, et al.
Clinical Pharmacology and Therapeutics
|
February 17, 2001
The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups
L M Mancinelli, L Frassetto, L C Floren, et al.
Clinical Pharmacology and Therapeutics
|
October 23, 1997
Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses
C Olbricht, C Wanner, T Eisenhauer, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 1, 1991
Investigations on the metabolic pathways of cyclosporine: I. Excretion of cyclosporine and its metabolites in human bile--isolation of 12 new cyclosporine metabolites
U Christians, S Strohmeyer, R Kownatzki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 1, 1991
Contribution of cyclosporin metabolites to immunosuppression in liver-transplanted patients with severe graft dysfunction
H J Schlitt, U Christians, J Bleck, et al.
Clinical Chemistry
|
September 1, 1996
Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry
F Streit, U Christians, H M Schiebel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 1999
Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver
W Jacobsen, G Kirchner, K Hallensleben, et al.
Pharmacology
|
August 18, 1999
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and Neoral
D M Canafax, W D Irish, H B Moran, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
November 25, 2000
Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants
U Christians, W Jacobsen, N Serkova, et al.
Pharmacology
|
January 1, 1989
Urinary excretion of ciclosporin and 17 of its metabolites in renal allograft recipients
J S Bleck, H J Schlitt, U Christians, et al.
Page
of 9